newsfilter
← Latest News
GlobeNewswire·

Prevail Therapeutics to Present at Upcoming October Conferences

NEW YORK, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL) (“Prevail” or “the Company”), a biotechnology company developing potentially disease-modifying AAV-based gene...